Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The 2nd PP

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Oct 06, 2022 1:26pm

118 Views

Post# 35009921

RE:RE:RE:RE:RE:RE:The 2nd PP

That's right.

Rumpl3StiltSkin wrote:

StevenBirch wrote: First of all I never said I wasn't biased, I am a long time and long term holder.

What I was saying is that they needed cash now, that just seems like a fact, and that long term it will take care of itself. It's obvious math that by waiting they could either raise more at a higher price or raise the same with fewer shares but the dilution now is still not any worry.

But who is filling these PP's? I know it's not me and we know a portion is insiders so who benefits by doing them at this level? It's naive to think otherwise and I'm not saying there is anything wrong with it either, that is the way of the world.

With all your warrant calculations you are forgetting one thing - we are very close to getting meaningful updates which could make 'manipulation' irrelevant. I guess my point was we don't need to see a bogeyman around every corner and remember that this entire scenario depends on one thing - results. If or when they are stellar and the appropriate approvals are granted then PP's, warrants, 4 month holds etc. mean absolutely nothing.

Just my opinion.

Infinity wrote: Steven, I am not so sure that you are all tha un-biased. I would like to respond to your remark here

"Third, if the PP's are filled by insiders and 'friends' why in the world would they wait until the price is higher, "

1. if the PP was done with a much higher selling price possibly after announcing the BTD application would have been at a much higher price resulting in more capital for the company.
2. The PP was announced at $0.25 possibly by vested interests of the company that I do not really get.
3. I would like to assume that anyone who owns 100,000 shares of TLT will sell their share at the current market price of $0.26 per share and at the same time purchase through the private placement at 0.25/Share plus a warrant that they can sell after 4 months of closing.
4. I agree the price of share and warrants may wary.
5, The warrants for some reason have been trading at about 50 to 65% of the share price. If I were the buyer, I would sell the warrant for around .13 cents and keep only shares that would bring my share cost price down to close to $ .12 cents. I can sell the shares at any price over that and still retain a profit.
Please explain how this would not lead to market manipulation encouraged by the management at the same time..
6. Do you sincerely believe if the PP was done at much higher price after the BTD application that the company would have LESS funds at their disposal?

Also Guys,

The total float of Shares/Warrants is ~ 320Mil. So the float hasn't changed much, yet it gives them a year + of operating capital. Which does assume at least some warrants coming in during that time so they can afford GLP and small Canadian based Phase 1(s)